Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Russia sees no hurdles for WHO approval of Sputnik V vaccine

Published 10/02/2021, 10:48 AM
Updated 10/02/2021, 10:51 AM
© Reuters. FILE PHOTO: An employee holds a vial containing Sputnik vaccine at a factory of Hankook Korus Pharm, in Chuncheon, South Korea September 10, 2021. Picture taken September 10, 2021.  REUTERS/Heo Ran

MOSCOW (Reuters) - All the barriers to register Russia's Sputnik V COVID-19 vaccine with the World Health Organization (WHO) have been cleared and only some paperwork remains to be completed, Russian Health Minister Mikhail Murashko said on Saturday.

The Sputnik V shot, widely used in Russia and approved for use in over 70 countries, is undergoing a review by the WHO and the European Medicines Agency (EMA). Their approval could open up new markets for the shot, especially in Europe.

Murashko has met WHO director-general Tedros Adhanom Ghebreyesus in Geneva.

"Russia's position on promotion and registration of the Sputnik V vaccine was heard, we have removed all the questions for today," Murashko was quoted as saying by Interfax news agency.

He said that the company which is dealing with Sputnik V registration at WHO only "has to sign a few documents, submit a few additional papers".

The WHO could not be immediately reached for comment.

The WHO said in July its review of how Russia produces the Sputnik V vaccine had found some issues with the filling of vials at one plant. The manufacturer said it had since addressed all of the WHO's concerns.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.